H1N1 TREATMENT US

LEIDEN, NETHERLANDS–(Marketwire – 02/09/10) – Crucell Announces Record Revenues and Profits for Full Year 2009 Total revenues and other operating income increased 26% to EUR358.0 million. Operating profit increased more than four-fold to EUR39.0 million. Net profit increased 68% to EUR23.9 million. Undiluted EPS increased 55% to EUR0.34. Year-end cash and short-term liquidities EUR428.0 million …

More here:
Crucell Announces Record Revenues and Profits for Full Year 2009 (Marketwire via Yahoo! Finance)

LEIDEN, NETHERLANDS–(Marketwire – 11/03/09) – Total revenues and other operating income increased by 15% to EUR 94.3 million. Operating profit of EUR 15.5 million versus EUR 9.6 million in Q3 2008. Quarter-end cash and short-term liquidities of EUR 411.9 million. Undiluted EPS of EUR 0.15 for the quarter. 2009 full year guidance reiterated: total revenues and other operating income expected to …

More here:
Crucell Announces Third Quarter 2009 Results (Marketwire via Yahoo! Finance)